188 related articles for article (PubMed ID: 31477351)
1. Optimization of 1,3-disubstituted urea-based inhibitors of Zika virus infection.
Khachatoorian R; Micewicz ED; Micewicz A; French SW; Ruchala P
Bioorg Med Chem Lett; 2019 Oct; 29(20):126626. PubMed ID: 31477351
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel small-molecule inhibitors of Zika virus infection.
Micewicz ED; Khachatoorian R; French SW; Ruchala P
Bioorg Med Chem Lett; 2018 Feb; 28(3):452-458. PubMed ID: 29258771
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
[TBL] [Abstract][Full Text] [Related]
4. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
7. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Discovery of N,N'-Carbazoyl-aryl-urea Inhibitors of Zika NS5 Methyltransferase and Virus Replication.
Spizzichino S; Mattedi G; Lauder K; Valle C; Aouadi W; Canard B; Decroly E; Kaptein SJF; Neyts J; Graham C; Sule Z; Barlow DJ; Silvestri R; Castagnolo D
ChemMedChem; 2020 Feb; 15(4):385-390. PubMed ID: 31805205
[TBL] [Abstract][Full Text] [Related]
9. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
[TBL] [Abstract][Full Text] [Related]
10. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors.
Zhu S; Zhang C; Huang LS; Zhang XQ; Xu Y; Fang X; Zhou J; Wu M; Schooley RT; Huang Z; An J
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013906
[TBL] [Abstract][Full Text] [Related]
11. Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.
Telehany SM; Humby MS; McGee TD; Riley SP; Jacobs A; Rizzo RC
Biochemistry; 2020 Oct; 59(39):3709-3724. PubMed ID: 32876433
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
[TBL] [Abstract][Full Text] [Related]
13. The A-Z of Zika drug discovery.
Mottin M; Borba JVVB; Braga RC; Torres PHM; Martini MC; Proenca-Modena JL; Judice CC; Costa FTM; Ekins S; Perryman AL; Horta Andrade C
Drug Discov Today; 2018 Nov; 23(11):1833-1847. PubMed ID: 29935345
[TBL] [Abstract][Full Text] [Related]
14. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.
Han Y; Mesplède T
Expert Opin Investig Drugs; 2018 Dec; 27(12):951-962. PubMed ID: 30430882
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targets and biological mechanisms of action of curcumin against Zika virus: In silico and in vitro analyses.
Kim M; Choi H; Kim YB
Eur J Pharmacol; 2021 Aug; 904():174144. PubMed ID: 33957087
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one.
Xu B; Lee EM; Medina A; Sun X; Wang D; Tang H; Zhou GC
Bioorg Chem; 2020 Nov; 104():104205. PubMed ID: 32916389
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
de Souza AAA; Torres LR; Capobianco LRPL; de Paula VS; Cascabulho CM; Salomão K; Bonecini-Almeida MDG; Ferreira MLG; Boechat N; Pinheiro LCDS; de Souza EM
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383619
[TBL] [Abstract][Full Text] [Related]
19. Strategies for Zika drug discovery.
Zou J; Shi PY
Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
[TBL] [Abstract][Full Text] [Related]
20. Current Breakthroughs in Structure-based Design of Synthetic and Natural Sourced Inhibitors Against Zika Viral Targets.
Nandi S; Kaur R; Kumar M; Sharma A; Naaz A; Mandal SC
Curr Top Med Chem; 2018; 18(20):1792-1803. PubMed ID: 30465510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
